News

Applications for the SPARK-BIH funding programme 2025 are open from now until 7 July 2025. Scientists and clinicians from BIH and Charité at all career levels are invited to apply.

Charité - Universitätsmedizin Berlin and the Berlin Institute of Health (BIH) now have fixed standard terms for spin-offs. These define binding key points for spin-off projects, particularly with regard to participation and licensing of intellectual property. Clear, consistent framework conditions create transparency, bindingness, and planning…

On February 20 2025, the Julius Wolff Institute, the BIH Center for Musculoskeletal Biomechanics and Regeneration, celebrated the opening of its new research areas in the Rahel Hirsch Center for Translational Medicine (RHC). To mark this major step, the team honored Dr. Julius Wolff, the person after whom the institute was named, with a ceremony.

A research team including Llorenç Solé Boldo and Simon Haas from the Berlin Institute of Health in der Charité (BIH), and other reseatchers from the Heidelberg Medical Faculty, the German Cancer Research Center (DKFZ), the Berlin Institute of Health at Charité (BIH) and the Max Delbrück Center has discovered new details about the spread of the…

The VADYS-ME research project investigates how vascular problems and circulatory disorders can trigger symptoms such as extreme fatigue and concentration problems in patients with ME/CFS. The project is led by Prof. Dr. Dr. med. Wolfram Döhner, a scientist at the Berlin Institute of Health (BIH) and the German Heart Center at Charité -…

Researchers at all stages of their careers, as well as institutions across all disciplines, are invited to apply for, or nominate colleagues for the prestigious, international €350,000 Einstein Foundation Award—the only award dedicated to recognizing exceptional contributions to advancing the rigor, reliability, robustness, and transparency of…

The consortium project CURE-ME (Characterizing AUtoimmuneREsponses and Defining Targets in ME/CFS) between the Berlin Institute of Health at Charité (BIH), Charité –Universitätsmedizin Berlin and the Technical University of Munich (TUM) will receive a total of €1,817,508 in grant funding from Germany’s Federal Ministry of Education and Research…

QUEST members Olmo van den Akker and Silke Kniffert have been elected to the steering group of the German Reproducibility Network.

A research team led by Prof. Dr. Georg Duda is endeavoring to innovate tissue engineering at the BIH Center for Regenerative Therapies (BCRT). In cooperation with industrial partner Cellbricks Therapeutics Inc., the team integrated a modern, light-based bioprinter that can produce these tissues by precisely combining different cell types with other…